Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Jan 2023)

A systematic review of measures of gender and biological sex: Exploring candidates for Alzheimer's disease and related dementias (AD/ADRD) research

  • Shana D. Stites,
  • Hannah Cao,
  • Richard James,
  • Kristin Harkins,
  • Cameron Coykendall,
  • Jason D. Flatt

DOI
https://doi.org/10.1002/dad2.12359
Journal volume & issue
Vol. 15, no. 1
pp. n/a – n/a

Abstract

Read online

Abstract Background Gender and biological sex are social and structural determinants of health and umbrella concepts encompassing many distinct attributes. This systematic review summarizes measures of gender and biological sex published in the biomedical literature. The goal was to identify measures that may be useful to researchers studying Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). Methods A search of PubMed, Embase, and PsycINFO (ProQuest platform) databases from 2000 to 2021 identified 1454 articles, which were then screened by five independent reviewers. Measures of gender and biological sex are summarized according to theoretical commitments and psychometric properties. Results Twenty‐nine measures were identified that assessed gender‐related constructs, and 4 were identified that assessed biological factors. Self‐report instruments characterized aspects of gender, such as gender stereotypes, norms, and ideologies. One measure was developed with a focus on older adults (65+ years). Discussion We offer recommendations to guide measurement of gender in AD/ADRD research, including how the use of specific existing measures may help advance AD/ADRD research. The lack of gender measures for older adults limits AD/ADRD research. New measures may be needed to address lifespan and generational differences in gender factors. Highlights A review of articles identifies 29 measures of gender in biomedical research. Gender is captured using multidimensional, self‐reported concepts. One measure was developed with a focus on older adults (65+).